Related references
Note: Only part of the references are listed.Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group
Arjan A. Loosdrecht et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2023)
Comparison of five diagnostic flow cytometry scores in patients with myelodysplastic syndromes: Diagnostic power and prognostic impact
Uta Oelschlaegel et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2023)
Clinical implications and genetic features of clonal cytopenia of undetermined significance compared to lower-risk myelodysplastic syndrome
Eun-Ji Choi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2022)
A predictive model for bone marrow disease in cytopenia based on noninvasive procedures
Dicte Traeden et al.
BLOOD ADVANCES (2022)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D. Khoury et al.
LEUKEMIA (2022)
The diagnostic and prognostic role of flow cytometry in idiopathic and clonal cytopenia of undetermined significance (ICUS/CCUS): A single-center analysis of 79 patients
Konstantinos Dinnopoulos et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2020)
Clinical Implication of Multi-Parameter Flow Cytometry in Myelodysplastic Syndromes
Carolien Duetz et al.
PATHOBIOLOGY (2019)
Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes
Eline M. P. Cremers et al.
HAEMATOLOGICA (2017)
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group
Theresia M. Westers et al.
HAEMATOLOGICA (2017)
Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes
Eline M. P. Cremers et al.
HAEMATOLOGICA (2017)
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group
Theresia M. Westers et al.
HAEMATOLOGICA (2017)
Clinical significance of somatic mutation in unexplained blood cytopenia
Luca Malcovati et al.
BLOOD (2017)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias
Eline M. P. Cremers et al.
EUROPEAN JOURNAL OF CANCER (2016)
Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia
Dorothee Selimoglu-Buet et al.
BLOOD (2015)
Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression
Catherine A. Cargo et al.
BLOOD (2015)
MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance
Brian Kwok et al.
BLOOD (2015)
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma et al.
BLOOD (2015)
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
T. Haferlach et al.
LEUKEMIA (2014)
Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS
A. Porwit et al.
LEUKEMIA (2014)
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil et al.
BLOOD (2013)
Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes
S. Mathis et al.
LEUKEMIA (2013)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study
Matteo G. Della Porta et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes
F. Xu et al.
INTERNAL MEDICINE JOURNAL (2012)
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
T. Kalina et al.
LEUKEMIA (2012)
Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group
T. M. Westers et al.
LEUKEMIA (2012)
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
J. J. M. van Dongen et al.
LEUKEMIA (2012)
Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS
Peter Valent et al.
LEUKEMIA RESEARCH (2012)
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clinical Utility of Multiparameter Flow Cytometry in the Diagnosis of 1013 Patients With Suspected Myelodysplastic Syndrome Correlation to Cytomorphology, cytogenetics, and Clinical Data
Wolfgang Kern et al.
CANCER (2010)
Normalization of Bone Marrow Aspirates for Hemodilution in Flow Cytometric Analyses
Michael R. Loken et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2009)
Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry
Arjan A. van de Loosdrecht et al.
BLOOD (2008)
Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference
Peter Valent et al.
LEUKEMIA RESEARCH (2007)
Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome
MG Della Porta et al.
LEUKEMIA (2006)
Share Paper
